Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Explosion hits US embassy in Oslo, causing minor damage, thick smoke
Four killed in Beirut hotel strike, Israel says it targeted Iranian commanders
Drone attacks cause major fire at Kuwait International Airport
Israel warns Lebanon of 'heavy price' as week's death toll nears 300
